Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
BMJ Case Reports|May 11, 2021
Ossified diagnosis: sarcoidosis masquerading as metastatic breast cancerMeiling MacDonald-Nethercott, Diana Ples, Ramona Woitek, et al.Breast (Edinburgh, Scotland)|July 12, 2017
Predicting treatment resistance and relapse through circulating DNAEmma Beddowes, Stephen J Sammut, Meiling Gao, et al.Annual Review of Biochemistry|March 23, 2019
Cancer Treatment in the Genomic EraGary J Doherty, Michele Petruzzelli, Emma Beddowes, et al.Computer Methods and Programs in Biomedicine|July 21, 2021
3D deformable registration of longitudinal abdominopelvic CT images using unsupervised deep learningMaureen van Eijnatten, Leonardo Rundo, K Joost Batenburg, et al.Genome Medicine|January 6, 2019
Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNAMeiling Gao, Maurizio Callari, Emma Beddowes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2017
Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic CancersEmma Beddowes, James Spicer, Pui Ying Chan, et al.The Journal of Clinical Investigation|March 5, 2013
IgG4 subclass antibodies impair antitumor immunity in melanomaPanagiotis Karagiannis, Amy E Gilbert, Debra H Josephs, et al.EMBO Molecular Medicine|May 10, 2023
Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancerAngela Santonja, Wendy N Cooper, Matthew D Eldridge, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer PatientsRichard D Baird, Annelot G J van Rossum, Mafalda Oliveira, et al.Pageof 1